OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 123 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,261,000 | +1744.6% | 45,313 | -88.9% | 0.18% | +2137.5% |
| Q1 2016 | $231,000 | -73.1% | 410,071 | -18.0% | 0.01% | -70.4% |
| Q4 2015 | $860,000 | -32.1% | 500,000 | -16.7% | 0.03% | -3.6% |
| Q3 2015 | $1,266,000 | -63.5% | 600,000 | -14.3% | 0.03% | -59.4% |
| Q2 2015 | $3,465,000 | -36.8% | 700,000 | 0.0% | 0.07% | -38.4% |
| Q1 2015 | $5,481,000 | +29.2% | 700,000 | 0.0% | 0.11% | +27.3% |
| Q4 2014 | $4,243,000 | +42.4% | 700,000 | 0.0% | 0.09% | +29.4% |
| Q3 2014 | $2,980,000 | -31.1% | 700,000 | 0.0% | 0.07% | -29.9% |
| Q2 2014 | $4,326,000 | -4.9% | 700,000 | 0.0% | 0.10% | -2.0% |
| Q1 2014 | $4,550,000 | +15.4% | 700,000 | 0.0% | 0.10% | +13.8% |
| Q4 2013 | $3,943,000 | -8.1% | 700,000 | 0.0% | 0.09% | -16.3% |
| Q3 2013 | $4,290,000 | +4.8% | 700,000 | 0.0% | 0.10% | -1.9% |
| Q2 2013 | $4,094,000 | – | 700,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,229,287 | $9,625,000 | 44.28% |
| Foresite Capital Management II, LLC | 4,200,047 | $32,886,000 | 19.48% |
| Scale Management, LLC | 2,884,305 | $22,584,000 | 11.28% |
| Cheyne Capital Management (UK) LLP | 1,484,409 | $11,601,000 | 2.80% |
| Telemetry Investments, L.L.C. | 463,039 | $3,626,000 | 2.00% |
| NEA Management Company, LLC | 3,709,000 | $29,041,000 | 1.31% |
| Rock Springs Capital Management LP | 1,550,000 | $12,137,000 | 1.14% |
| Rhenman & Partners Asset Management AB | 831,800 | $6,513,000 | 1.10% |
| Tamarack Capital Management, LLC | 1,000,000 | $7,830,000 | 1.03% |
| RA Capital Management | 1,186,229 | $9,288,000 | 0.92% |